De Windt LJ - Search Results

1

Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy.

Taigen T, De Windt LJ, Lim HW, Molkentin JD. Taigen T, et al. Among authors: de windt lj. Proc Natl Acad Sci U S A. 2000 Feb 1;97(3):1196-201. doi: 10.1073/pnas.97.3.1196. Proc Natl Acad Sci U S A. 2000. PMID: 10655507 Free PMC article.

2

Targeted disruption of NFATc3, but not NFATc4, reveals an intrinsic defect in calcineurin-mediated cardiac hypertrophic growth.

Wilkins BJ, De Windt LJ, Bueno OF, Braz JC, Glascock BJ, Kimball TF, Molkentin JD. Wilkins BJ, et al. Among authors: de windt lj. Mol Cell Biol. 2002 Nov;22(21):7603-13. doi: 10.1128/MCB.22.21.7603-7613.2002. Mol Cell Biol. 2002. PMID: 12370307 Free PMC article.

3

Modulatory calcineurin-interacting proteins 1 and 2 function as calcineurin facilitators in vivo.

Sanna B, Brandt EB, Kaiser RA, Pfluger P, Witt SA, Kimball TR, van Rooij E, De Windt LJ, Rothenberg ME, Tschop MH, Benoit SC, Molkentin JD. Sanna B, et al. Among authors: de windt lj. Proc Natl Acad Sci U S A. 2006 May 9;103(19):7327-32. doi: 10.1073/pnas.0509340103. Epub 2006 Apr 28. Proc Natl Acad Sci U S A. 2006. PMID: 16648267 Free PMC article.

4

Calcineurin-mediated hypertrophy protects cardiomyocytes from apoptosis in vitro and in vivo: An apoptosis-independent model of dilated heart failure.

De Windt LJ, Lim HW, Taigen T, Wencker D, Condorelli G, Dorn GW 2nd, Kitsis RN, Molkentin JD. De Windt LJ, et al. Circ Res. 2000 Feb 18;86(3):255-63. doi: 10.1161/01.res.86.3.255. Circ Res. 2000. PMID: 10679475

5

Reversal of cardiac hypertrophy in transgenic disease models by calcineurin inhibition.

Lim HW, De Windt LJ, Mante J, Kimball TR, Witt SA, Sussman MA, Molkentin JD. Lim HW, et al. Among authors: de windt lj. J Mol Cell Cardiol. 2000 Apr;32(4):697-709. doi: 10.1006/jmcc.2000.1113. J Mol Cell Cardiol. 2000. PMID: 10756124

6

Calcineurin expression, activation, and function in cardiac pressure-overload hypertrophy.

Lim HW, De Windt LJ, Steinberg L, Taigen T, Witt SA, Kimball TR, Molkentin JD. Lim HW, et al. Among authors: de windt lj. Circulation. 2000 May 23;101(20):2431-7. doi: 10.1161/01.cir.101.20.2431. Circulation. 2000. PMID: 10821822

7

A calcineurin-NFATc3-dependent pathway regulates skeletal muscle differentiation and slow myosin heavy-chain expression.

Delling U, Tureckova J, Lim HW, De Windt LJ, Rotwein P, Molkentin JD. Delling U, et al. Among authors: de windt lj. Mol Cell Biol. 2000 Sep;20(17):6600-11. doi: 10.1128/MCB.20.17.6600-6611.2000. Mol Cell Biol. 2000. PMID: 10938134 Free PMC article.

8

The dual-specificity phosphatase MKP-1 limits the cardiac hypertrophic response in vitro and in vivo.

Bueno OF, De Windt LJ, Lim HW, Tymitz KM, Witt SA, Kimball TR, Molkentin JD. Bueno OF, et al. Among authors: de windt lj. Circ Res. 2001 Jan 19;88(1):88-96. doi: 10.1161/01.res.88.1.88. Circ Res. 2001. PMID: 11139479

9

Targeted inhibition of calcineurin attenuates cardiac hypertrophy in vivo.

De Windt LJ, Lim HW, Bueno OF, Liang Q, Delling U, Braz JC, Glascock BJ, Kimball TF, del Monte F, Hajjar RJ, Molkentin JD. De Windt LJ, et al. Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3322-7. doi: 10.1073/pnas.031371998. Proc Natl Acad Sci U S A. 2001. PMID: 11248077 Free PMC article.

10

The transcription factors GATA4 and GATA6 regulate cardiomyocyte hypertrophy in vitro and in vivo.

Liang Q, De Windt LJ, Witt SA, Kimball TR, Markham BE, Molkentin JD. Liang Q, et al. Among authors: de windt lj. J Biol Chem. 2001 Aug 10;276(32):30245-53. doi: 10.1074/jbc.M102174200. Epub 2001 May 16. J Biol Chem. 2001. PMID: 11356841 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

160 results

Search Page

Filters